Drug class · Hematology
Erythropoiesis-stimulating agents
Biologics that stimulate red blood cell production, such as epoetin alfa and darbepoetin alfa.
Most-listed names in this class
Ranked by the number of FDA listings, which reflects labelers and package variety — not sales or prescribing.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Aranespdarbepoetin alfa | Darbepoetin alfa 25 ug/mL | SolutionIntravenous, Subcutaneous | Amgen, Inc | 55513-002 |
| Aranespdarbepoetin alfa | Darbepoetin alfa 40 ug/mL | SolutionIntravenous, Subcutaneous | Amgen, Inc | 55513-003 |
| Aranespdarbepoetin alfa | Darbepoetin alfa 60 ug/mL | SolutionIntravenous, Subcutaneous | Amgen, Inc | 55513-004 |
| Aranespdarbepoetin alfa | Darbepoetin alfa 100 ug/mL | SolutionIntravenous, Subcutaneous | Amgen, Inc | 55513-005 |
| Aranespdarbepoetin alfa | Darbepoetin alfa 100 ug/.5mL | Injection, SolutionIntravenous, Subcutaneous | Amgen, Inc | 55513-025 |
| Aranespdarbepoetin alfa | Darbepoetin alfa 200 ug/mL | SolutionIntravenous, Subcutaneous | Amgen, Inc | 55513-006 |
| Aranespdarbepoetin alfa | Darbepoetin alfa 40 ug/.4mL | Injection, SolutionIntravenous, Subcutaneous | Amgen, Inc | 55513-021 |
| Aranespdarbepoetin alfa | Darbepoetin alfa 60 ug/.3mL | Injection, SolutionIntravenous, Subcutaneous | Amgen, Inc | 55513-023 |
| Aranespdarbepoetin alfa | Darbepoetin alfa 150 ug/.3mL | Injection, SolutionIntravenous, Subcutaneous | Amgen, Inc | 55513-027 |
| Aranespdarbepoetin alfa | Darbepoetin alfa 200 ug/.4mL | Injection, SolutionIntravenous, Subcutaneous | Amgen, Inc | 55513-028 |
| Aranespdarbepoetin alfa | Darbepoetin alfa 500 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Amgen, Inc | 55513-032 |
| Aranespdarbepoetin alfa | Darbepoetin alfa 25 ug/.42mL | Injection, SolutionIntravenous, Subcutaneous | Amgen, Inc | 55513-057 |
| Aranespdarbepoetin alfa | Darbepoetin alfa 10 ug/.4mL | Injection, SolutionIntravenous, Subcutaneous | Amgen, Inc | 55513-098 |
| Aranespdarbepoetin alfa | Darbepoetin alfa 300 ug/.6mL | Injection, SolutionIntravenous, Subcutaneous | Amgen, Inc | 55513-111 |
| Epogenepoetin alfa | Epoetin 2000 [iU]/mL | SolutionIntravenous, Subcutaneous | Amgen, Inc | 55513-126 |
| Epogenepoetin alfa | Epoetin 10000 [iU]/mL | SolutionIntravenous, Subcutaneous | Amgen, Inc | 55513-144 |
| Epogenepoetin alfa | Epoetin 4000 [iU]/mL | SolutionIntravenous, Subcutaneous | Amgen, Inc | 55513-148 |
| Epogenepoetin alfa | Epoetin 3000 [iU]/mL | SolutionIntravenous, Subcutaneous | Amgen, Inc | 55513-267 |
| Epogenepoetin alfa | Epoetin 10000 [iU]/mL | SolutionIntravenous, Subcutaneous | Amgen, Inc | 55513-283 |
| Epogenepoetin alfa | Epoetin 20000 [iU]/mL | SolutionIntravenous, Subcutaneous | Amgen, Inc | 55513-478 |
| Mirceramethoxy polyethylene glycol-epoetin beta | Methoxy polyethylene glycol-epoetin beta 50 ug/.3mL | Injection, SolutionIntravenous | Vifor (International) Inc. | 59353-401 |
| Mirceramethoxy polyethylene glycol-epoetin beta | Methoxy polyethylene glycol-epoetin beta 30 ug/.3mL | Injection, SolutionIntravenous | Vifor (International) Inc. | 59353-400 |
| Mirceramethoxy polyethylene glycol-epoetin beta | Methoxy polyethylene glycol-epoetin beta 200 ug/.3mL | Injection, SolutionIntravenous | Vifor (International) Inc. | 59353-405 |
| Mirceramethoxy polyethylene glycol-epoetin beta | Methoxy polyethylene glycol-epoetin beta 75 ug/.3mL | Injection, SolutionIntravenous | Vifor (International) Inc. | 59353-402 |
| Mirceramethoxy polyethylene glycol-epoetin beta | Methoxy polyethylene glycol-epoetin beta 100 ug/.3mL | Injection, SolutionIntravenous | Vifor (International) Inc. | 59353-403 |